Moderna’s Covid-19 vaccine led patients to produce antibodies that can neutralize the novel coronavirus that causes the disease, though it caused minor side effects in many patients, according to the first published data from an early-stage trial of the experimental shot. The results were published Tuesday in the New England Journal of Medicine. Moderna had previously released some
Moderna expects to start late-stage COVID-19 vaccine trial on July 27
